Literature DB >> 12391297

Biological activity of the Helicobacter pylori virulence factor CagA is determined by variation in the tyrosine phosphorylation sites.

Hideaki Higashi1, Ryouhei Tsutsumi, Akiko Fujita, Shiho Yamazaki, Masahiro Asaka, Takeshi Azuma, Masanori Hatakeyama.   

Abstract

Helicobacter pylori is a causative agent of gastritis and peptic ulcer. cagA(+) H. pylori strains are more virulent than cagA(-) strains and are associated with gastric carcinoma. The cagA gene product, CagA, is injected by the bacterium into gastric epithelial cells and subsequently undergoes tyrosine phosphorylation. The phosphorylated CagA specifically binds SHP-2 phosphatase, activates the phosphatase activity, and thereby induces morphological transformation of cells. CagA proteins of most Western H. pylori isolates have a 34-amino acid sequence that variably repeats among different strains. Here, we show that the repeat sequence contains a tyrosine phosphorylation site. CagA proteins having more repeats were found to undergo greater tyrosine phosphorylation, to exhibit increased SHP-2 binding, and to induce greater morphological changes. In contrast, predominant CagA proteins specified by H. pylori strains isolated in East Asia, where gastric carcinoma is prevalent, had a distinct tyrosine phosphorylation sequence at the region corresponding to the repeat sequence of Western CagA. This East Asian-specific sequence conferred stronger SHP-2 binding and morphologically transforming activities to Western CagA. Finally, a critical amino acid residue that determines SHP-2 binding activity among different CagA proteins was identified. Our results indicate that the potential of individual CagA to perturb host-cell functions is determined by the degree of SHP-2 binding activity, which depends in turn on the number and sequences of tyrosine phosphorylation sites. The presence of distinctly structured CagA proteins in Western and East Asian H. pylori isolates may underlie the strikingly different incidences of gastric carcinoma in these two geographic areas.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12391297      PMCID: PMC137900          DOI: 10.1073/pnas.222375399

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  35 in total

1.  Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer.

Authors:  J Q Huang; S Sridhar; Y Chen; R H Hunt
Journal:  Gastroenterology       Date:  1998-06       Impact factor: 22.682

2.  Analyses of the cag pathogenicity island of Helicobacter pylori.

Authors:  N S Akopyants; S W Clifton; D Kersulyte; J E Crabtree; B E Youree; C A Reece; N O Bukanov; E S Drazek; B A Roe; D E Berg
Journal:  Mol Microbiol       Date:  1998-04       Impact factor: 3.501

3.  c-Src/Lyn kinases activate Helicobacter pylori CagA through tyrosine phosphorylation of the EPIYA motifs.

Authors:  Markus Stein; Fabio Bagnoli; Robert Halenbeck; Rino Rappuoli; Wendy J Fantl; Antonello Covacci
Journal:  Mol Microbiol       Date:  2002-02       Impact factor: 3.501

4.  Patients younger than 40 years with gastric carcinoma: Helicobacter pylori genotype and associated gastritis phenotype.

Authors:  M Rugge; G Busatto; M Cassaro; Y H Shiao; V Russo; G Leandro; C Avellini; A Fabiano; A Sidoni; A Covacci
Journal:  Cancer       Date:  1999-06-15       Impact factor: 6.860

5.  Helicobacter pylori infection induces gastric cancer in mongolian gerbils.

Authors:  T Watanabe; M Tada; H Nagai; S Sasaki; M Nakao
Journal:  Gastroenterology       Date:  1998-09       Impact factor: 22.682

6.  Activation of the SH2-containing phosphotyrosine phosphatase SH-PTP2 by its binding site, phosphotyrosine 1009, on the human platelet-derived growth factor receptor.

Authors:  R J Lechleider; S Sugimoto; A M Bennett; A S Kashishian; J A Cooper; S E Shoelson; C T Walsh; B G Neel
Journal:  J Biol Chem       Date:  1993-10-15       Impact factor: 5.157

7.  SH2 domains from suppressor of cytokine signaling-3 and protein tyrosine phosphatase SHP-2 have similar binding specificities.

Authors:  David De Souza; Louis J Fabri; Andrew Nash; Douglas J Hilton; Nicos A Nicola; Manuel Baca
Journal:  Biochemistry       Date:  2002-07-23       Impact factor: 3.162

8.  Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori.

Authors:  R A Alm; L S Ling; D T Moir; B L King; E D Brown; P C Doig; D R Smith; B Noonan; B C Guild; B L deJonge; G Carmel; P J Tummino; A Caruso; M Uria-Nickelsen; D M Mills; C Ives; R Gibson; D Merberg; S D Mills; Q Jiang; D E Taylor; G F Vovis; T J Trust
Journal:  Nature       Date:  1999-01-14       Impact factor: 49.962

9.  Development of Helicobacter pylori-induced gastric carcinoma in Mongolian gerbils.

Authors:  S Honda; T Fujioka; M Tokieda; R Satoh; A Nishizono; M Nasu
Journal:  Cancer Res       Date:  1998-10-01       Impact factor: 12.701

10.  Variants of the 3' region of the cagA gene in Helicobacter pylori isolates from patients with different H. pylori-associated diseases.

Authors:  Y Yamaoka; T Kodama; K Kashima; D Y Graham; A R Sepulveda
Journal:  J Clin Microbiol       Date:  1998-08       Impact factor: 5.948

View more
  213 in total

1.  A novel inhibitory domain of Helicobacter pylori protein CagA reduces CagA effects on host cell biology.

Authors:  Christiane Pelz; Sylvia Steininger; Claudia Weiss; Fabian Coscia; Roger Vogelmann
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

Review 2.  Helicobacter pylori Eradication in Patients with Immune Thrombocytopenic Purpura: A Review and the Role of Biogeography.

Authors:  Galit H Frydman; Nick Davis; Paul L Beck; James G Fox
Journal:  Helicobacter       Date:  2015-03-01       Impact factor: 5.753

3.  Signature of positive selection of PTK6 gene in East Asian populations: a cross talk for Helicobacter pylori invasion and gastric cancer endemicity.

Authors:  Pankaj Jha; Dongsheng Lu; Yuan Yuan; Shuhua Xu
Journal:  Mol Genet Genomics       Date:  2015-04-03       Impact factor: 3.291

Review 4.  Overview: Helicobacter pylori and extragastric disease.

Authors:  Hidekazu Suzuki; Barry James Marshall; Toshifumi Hibi
Journal:  Int J Hematol       Date:  2006-11       Impact factor: 2.490

Review 5.  Polymorphism in the Helicobacter pylori CagA and VacA toxins and disease.

Authors:  Dacie R Bridge; D Scott Merrell
Journal:  Gut Microbes       Date:  2013-02-04

Review 6.  Pathobiology of Helicobacter pylori-Induced Gastric Cancer.

Authors:  Manuel Amieva; Richard M Peek
Journal:  Gastroenterology       Date:  2015-09-16       Impact factor: 22.682

7.  A new subtype of 3' region of cagA gene in Helicobacter pylori strains isolated from Zhejiang Province in China.

Authors:  Ran Tao; Ping-Chu Fang; Hai-Yan Liu; Yun-Shui Jiang; Jing Chen
Journal:  World J Gastroenterol       Date:  2004-11-15       Impact factor: 5.742

Review 8.  H. pylori infection, inflammation and gastric cancer.

Authors:  Qurteeba Qadri; Roohi Rasool; G M Gulzar; Sameer Naqash; Zafar A Shah
Journal:  J Gastrointest Cancer       Date:  2014-06

9.  Host SHP1 phosphatase antagonizes Helicobacter pylori CagA and can be downregulated by Epstein-Barr virus.

Authors:  Priya Saju; Naoko Murata-Kamiya; Takeru Hayashi; Yoshie Senda; Lisa Nagase; Saori Noda; Keisuke Matsusaka; Sayaka Funata; Akiko Kunita; Masayuki Urabe; Yasuyuki Seto; Masashi Fukayama; Atsushi Kaneda; Masanori Hatakeyama
Journal:  Nat Microbiol       Date:  2016-03-14       Impact factor: 17.745

10.  Evaluation of the anti-East Asian CagA-specific antibody for CagA phenotyping.

Authors:  Lam Tung Nguyen; Tomohisa Uchida; Akiko Kuroda; Yoshiyuki Tsukamoto; Tuan Dung Trinh; Long Ta; Hong Bang Mai; Dang Quy Dung Ho; Hoa Hai Hoang; Ratha-Korn Vilaichone; Varocha Mahachai; Takeshi Matsuhisa; Yoko Kudo; Tadayoshi Okimoto; Masaaki Kodama; Kazunari Murakami; Toshio Fujioka; Yoshio Yamaoka; Masatsugu Moriyama
Journal:  Clin Vaccine Immunol       Date:  2009-09-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.